Terms ending in 2034
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D838,840 | Injector Device In force · High confidence | AbbVie Biotechnology Ltd. (Puerto Rico Branch) | In force | High confidence | |
| US D839,584 | Medication Packaging and Dispensing System In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,184,003 | Prolactin Receptor Binding Proteins and Uses Thereof In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| US 10,081,628 | Apoptosis-Inducing Agents for the Treatment of Cancer and Immune and Autoimmune Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,655,964 | Bispecific Antibodies Directed Against Tnf-A and IL-17 In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| US 8,980,879 | Bromodomain Inhibitors In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,050,346 | Bromodomain Inhibitors In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,921,526 | MUTATED ANTI-TNFa ANTIBODIES AND METHODS OF THEIR USE In force · High confidence | AbbVie, Inc. | In force | High confidence | |
| US 9,006,438 | Processes For The Preparation Of An Apoptosis-Inducing Agent In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,199,992 | Processes for the Preparation of an Apoptosis-Inducing Agent In force · High confidence | AbbVie Inc. | In force | High confidence | |
| 37 more term ends in 2034 · Pro | |||||
10 of 47 patents shown. Soonest term end first, then patent number.
Pro members see all 47.
43 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.